- Home
- KMDA vs ZYXI Comparison
KMDA vs ZYXI Comparison
Compare KMDA & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- ZYXI
- Stock Information
- Founded
- KMDA 1990
- ZYXI 1996
- Country
- KMDA Israel
- ZYXI United States
- Employees
- KMDA N/A
- ZYXI N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KMDA Health Care
- ZYXI Health Care
- Exchange
- KMDA Nasdaq
- ZYXI Nasdaq
- Market Cap
- KMDA 310.1M
- ZYXI 257.1M
- IPO Year
- KMDA N/A
- ZYXI N/A
- Fundamental
- Price
- KMDA $5.97
- ZYXI $8.92
- Analyst Decision
- KMDA Strong Buy
- ZYXI Strong Buy
- Analyst Count
- KMDA 2
- ZYXI 2
- Target Price
- KMDA $14.50
- ZYXI $14.00
- AVG Volume (30 Days)
- KMDA 40.9K
- ZYXI 120.1K
- Earning Date
- KMDA 11-13-2024
- ZYXI 10-24-2024
- Dividend Yield
- KMDA N/A
- ZYXI N/A
- EPS Growth
- KMDA 230.67
- ZYXI N/A
- EPS
- KMDA 0.25
- ZYXI 0.15
- Revenue
- KMDA $154,574,000.00
- ZYXI $193,665,000.00
- Revenue This Year
- KMDA $14.85
- ZYXI $10.70
- Revenue Next Year
- KMDA $7.64
- ZYXI $19.78
- P/E Ratio
- KMDA $22.94
- ZYXI $60.06
- Revenue Growth
- KMDA 6.01
- ZYXI 4.21
- 52 Week Low
- KMDA $4.58
- ZYXI $7.15
- 52 Week High
- KMDA $6.53
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- KMDA 77.16
- ZYXI 54.55
- Support Level
- KMDA $5.84
- ZYXI $7.97
- Resistance Level
- KMDA $6.06
- ZYXI $9.30
- Average True Range (ATR)
- KMDA 0.12
- ZYXI 0.39
- MACD
- KMDA 0.07
- ZYXI 0.01
- Stochastic Oscillator
- KMDA 91.57
- ZYXI 55.17
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.